Management of recurrent in-stent restenosis: onion skin full metal jacket?

EuroIntervention 2013;9:781-785. DOI: 10.4244/EIJV9I7A129

Fernando Alfonso
Fernando Alfonso1*, MD, PhD, FESC; Bruno Scheller2, MD, PhD
1. Cardiac Department, Hospital Universitario de La Princesa, IIS-IP, Universidad Autónoma de Madrid, Madrid, Spain; 2. Clinical and Experimental Interventional Cardiology, University of Saarland, Homburg/Saar, Germany
Treatment of patients with in-stent restenosis (ISR) remains a technical challenge and continues to represent a major clinical problem1. Although bare metal stents (BMS) are still widely used they suffer from a relatively high restenosis rate, especially in complex clinical and anatomic scenarios1,2. Drug-eluting stents (DES) have drastically reduced the appearance of severe neointimal proliferation and the clinical need for repeat revascularisation. However, some patients treated with DES still develop ISR1,2. Timing, morphological patterns, underlying substrate and response to treatment differ slightly in patients with DES-ISR and those with BMS-ISR1. Indeed, DES-ISR may present relatively late after the initial procedure, ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The EAPCI welcomes the new WOMEN initiative

Latest news